This may have significance for breast cancer in that S-(–)equol producer status has been linked to lower breast cancer risk [89]; however, further studies are needed to evaluate the bacterial metabolism of soy isoflavones in breast cancer patients whose tumors contain distinct estrogen receptor profiles. Here, ESR1 is linked to breast carcinoma.